AI assistant
LEAP THERAPEUTICS, INC. — Director's Dealing 2017
Jan 24, 2017
35080_dirs_2017-01-23_156acf13-afff-4294-9c0e-887eedbc5a74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2017-01-20
Reporting Person: HealthCare Ventures VIII, L.P. (10% Owner)
Reporting Person: HealthCare Partners VIII, L.P. (10% Owner)
Reporting Person: HealthCare Partners VIII, LLC (10% Owner)
Reporting Person: WERNER HAROLD R (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2618406 | Direct |
Footnotes
F1: 2,618,406 shares are held of record by HealthCare Ventures VIII, L.P. Christopher K. Mirabelli, James H. Cavanaugh, John W. Littlechild, Harold Werner and Augustine Lawlor (collectively, the "HCVVIII Directors") are the Managing Directors of HealthCare Partners VIII, LLC ("HCPVIII LLC"), which is the General Partner of HealthCare Partners VIII, L.P. ("HCPVIII"), which is the General Partner of HealthCare Ventures VIII, L.P. Each of the HCVVIII Directors, including Harold Werner, HCPVIII LLC and HCPVIII indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures VIII, L.P and disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities.